On the other hand, two genes (CYP1A2 and FMO1) were downregulated in hepatotoxicity pathway, two genes (SREBF1 and FASN) in steatosis, one each in necrosis (IPO4) and phospholipidosis (SLC2A3) pathways. The gene discussed is SLC2A3; the disease is steatosis.